{"title":"The Postoperative S Wave in Lead V<sub>5</sub> and/or V<sub>6</sub> Predicts Better Clinical Outcomes in Heart Failure Patients With Left Bundle Branch Area Pacing.","authors":"Kailun Zhu, Chen He, Haojie Zhu, Chuangshi Wang, Xiaofei Li, Xiaohan Fan","doi":"10.1111/pace.70031","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>S wave in lead V<sub>5/6</sub> has been reported as a marker indicated for successful left bundle branch (LBB) capture. This study aimed to evaluate the value of the S wave in lead V<sub>5/6</sub> in predicting the long-term clinical outcomes in heart failure (HF) patients treated with left bundle area pacing (LBBAP).</p><p><strong>Methods: </strong>Consecutive HF patients receiving LBBAP were prospectively enrolled and followed at least 2 years. ECG were analyzed to identify the S wave in lead V<sub>5/6</sub>. The composite end point was all-cause mortality, HF hospitalization, and malignant ventricular arrhythmias. Non-response to LBBAP delivered cardiac resynchronization therapy (CRT) was defined as left ventricular ejection fraction improvement <5% at 6 months after implantation.</p><p><strong>Results: </strong>A total of 57 patients were included with the mean age of 59.90 ± 12.57 years and 39 (68.42%) males. S wave in V<sub>5/6</sub> was observed in 38 patients. During a mean follow up of 29.84 ± 12.51 months, Kaplan-Meier curves showed a 77.8% reduction in risk of composite end point for V<sub>5/6</sub> with S (HR 0.222; 95% CI 0.065, 0.756; log-rank, p = 0.0069). Multivariate Cox regression analysis revealed that V<sub>5/6</sub> with S was associated with a lower risk of the composite end point by 69.0% (adjusted HR 0.31; 95% CI 0.09, 1.05; p = 0.041). The non-response rate of LBBAP was 22.58% in V<sub>5/6</sub> with S and 58.82% in V<sub>5/6</sub> without S (p = 0.012).</p><p><strong>Conclusion: </strong>S wave in lead V<sub>5</sub> and/or V<sub>6</sub> after LBBAP predicts better clinical outcomes, and has a better response rate of LBBAP for CRT in HF patients.</p>","PeriodicalId":520740,"journal":{"name":"Pacing and clinical electrophysiology : PACE","volume":" ","pages":"1077-1085"},"PeriodicalIF":1.3000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pacing and clinical electrophysiology : PACE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/pace.70031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: S wave in lead V5/6 has been reported as a marker indicated for successful left bundle branch (LBB) capture. This study aimed to evaluate the value of the S wave in lead V5/6 in predicting the long-term clinical outcomes in heart failure (HF) patients treated with left bundle area pacing (LBBAP).
Methods: Consecutive HF patients receiving LBBAP were prospectively enrolled and followed at least 2 years. ECG were analyzed to identify the S wave in lead V5/6. The composite end point was all-cause mortality, HF hospitalization, and malignant ventricular arrhythmias. Non-response to LBBAP delivered cardiac resynchronization therapy (CRT) was defined as left ventricular ejection fraction improvement <5% at 6 months after implantation.
Results: A total of 57 patients were included with the mean age of 59.90 ± 12.57 years and 39 (68.42%) males. S wave in V5/6 was observed in 38 patients. During a mean follow up of 29.84 ± 12.51 months, Kaplan-Meier curves showed a 77.8% reduction in risk of composite end point for V5/6 with S (HR 0.222; 95% CI 0.065, 0.756; log-rank, p = 0.0069). Multivariate Cox regression analysis revealed that V5/6 with S was associated with a lower risk of the composite end point by 69.0% (adjusted HR 0.31; 95% CI 0.09, 1.05; p = 0.041). The non-response rate of LBBAP was 22.58% in V5/6 with S and 58.82% in V5/6 without S (p = 0.012).
Conclusion: S wave in lead V5 and/or V6 after LBBAP predicts better clinical outcomes, and has a better response rate of LBBAP for CRT in HF patients.